A three-year ophthalmology coordinator on imaging integration, independent reading centers, and the one staffing problem no scheduling software has solved yet.
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Improving Oncology Trial Experiences & Efficiencies Digital Solutions
Uncover how a top-10 pharmaceutical company was able to overcome oncology clinical study obstacles with a digital software platform.
-
Moving Towards AI, ML, And Trial Platforms For True Scalability
Uncover why AI, ML, and clinical trial platforms have the potential to create true scalability across an organization's entire pipeline, and reduce timelines by YEARS.
-
6 Ways Sponsors & CROs Are Optimizing Site Performance
See how Florence’s Site Enablement Platform works to overcome common trial hurdles and improve clinical trial operations, accelerate studies, and streamline compliance.
-
Why eCOA Data Reporting Often Falls Short (And What To Do About It)
By nature, eCOA and ePRO solutions are designed so it’s easy for clinicians and patients to provide clinical trial information. But this is only part of the equation. Discover how eCOA and ePRO solutions also need a thoughtful back-end experience.
-
The Regulatory Governance Gap In Clinical Trial AI
Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.
-
Harnessing The Power Of eCOA Technology
Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.
-
How eConsent Improves The Trial Experience For Patients And Sites
In part one of this series, the author dives into how electronic consent platforms are simplifying and improving the trial experience for patients and sites.
-
Accelerating CRO Study Deployment At Scale
A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.
-
EDC Selected To Support Biotech Advances In Diabetes
Find out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.
-
Atlantic Research Group Builds Competitive Advantage With Medrio EDC
By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
RECENT NEWSLETTERS
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch